The VDAC (voltage-dependent anion channel) is proposed to control metabolic cross-talk between mitochondria and the cytosol, as well as apoptotic cell death. It has been suggested that apoptosis is modulated by the oxidation state of VDAC. Since cysteine residues are the major target for oxidation/reduction, we verified whether one or both VDAC1 cysteine residues are involved in VDAC1-mediated transport or apoptosis activities. To assess the function of VDAC1 cysteine residues in channel activity and to probe cysteine topology with respect to facing the pore or the bilayer, we used thiol-modifying agents, namely membrane-permeable NEM (N-ethylmaleimide), bulky charged 5-FM (fluorescein-5-maleimide) and the cross-linking reagent BMOE [bis(maleimido)ethane]. Bilayer-reconstituted VDAC conductance was decreased by 5-FM, but not by NEM, whereas 5-FM had no effect on NEM-labelled VDAC conductance. BMOE caused the formation of dimeric VDAC1, suggesting that one of the two VDAC1 cysteine residues is exposed and available for cross-linking. The results thus suggest that one of the VDAC1 cysteine residues faces the VDAC pore, whereas the second is oriented towards the lipid bilayer. Mutated rat VDAC1 in which the two cysteine residues, Cys 127 and Cys 232 , were replaced by alanine residues showed channel activity like native VDAC1 and, when expressed in cells, was localized to mitochondria. Human VDAC1-shRNA (small hairpin RNA)-or -siRNA (small interfering RNA)-treated cells, expressing low levels of endogenous human VDAC1 together with native or cysteine-less rat VDAC1, undergo apoptosis as induced by overexpression of these VDAC1 or upon treatment with reactive oxygen species-producing agents, H 2 O 2 , As 2 O 3 or selenite, suggesting that the two cysteine residues are not required for apoptosis or VDAC1 oligomerization.
The VDAC (voltage-dependent anion channel) is proposed to control metabolic cross-talk between mitochondria and the cytosol, as well as apoptotic cell death. It has been suggested that apoptosis is modulated by the oxidation state of VDAC. Since cysteine residues are the major target for oxidation/reduction, we verified whether one or both VDAC1 cysteine residues are involved in VDAC1-mediated transport or apoptosis activities. To assess the function of VDAC1 cysteine residues in channel activity and to probe cysteine topology with respect to facing the pore or the bilayer, we used thiol-modifying agents, namely membrane-permeable NEM (N-ethylmaleimide), bulky charged 5-FM (fluorescein-5-maleimide) and the cross-linking reagent BMOE [bis(maleimido)ethane]. Bilayer-reconstituted VDAC conductance was decreased by 5-FM, but not by NEM, whereas 5-FM had no effect on NEM-labelled VDAC conductance. BMOE caused the formation of dimeric VDAC1, suggesting that one of the two VDAC1 cysteine residues is exposed and available for cross-linking. The results thus suggest that one of the VDAC1 cysteine residues faces the VDAC pore, whereas the second is oriented towards the lipid bilayer. Mutated rat VDAC1 in which the two cysteine residues, Cys 127 and Cys 232 , were replaced by alanine residues showed channel activity like native VDAC1 and, when expressed in cells, was localized to mitochondria. Human VDAC1-shRNA (small hairpin RNA)-or -siRNA (small interfering RNA)-treated cells, expressing low levels of endogenous human VDAC1 together with native or cysteine-less rat VDAC1, undergo apoptosis as induced by overexpression of these VDAC1 or upon treatment with reactive oxygen species-producing agents, H 2 O 2 , As 2 O 3 or selenite, suggesting that the two cysteine residues are not required for apoptosis or VDAC1 oligomerization.
INTRODUCTION
Mitochondria represent both a major source for ROS (reactive oxygen species) production and a target for oxidative macromolecular damage [1] . ROS arise transiently during normal metabolism as toxic by-products of respiratory chain reactions and have been shown to accumulate under conditions of oxidative stress [1] . Accumulating evidence also indicates that ROS play a key role in cytochrome c release from mitochondria and activate apoptosis [2] [3] [4] . Indeed, it has been shown that apoptosisinducing agents, such as inorganic arsenic trioxide (As 2 O 3 ) [5, 6] , cause oxidative damage to DNA and protein by inducing ROS generation. Cysteine residues, often involved in redox reactions, metal co-ordination and thiol-disulfide interchanges, are extremely vulnerable to oxidation by ROS.
It has been suggested that mitochondrial-induced ROS production and promotion of cytochrome c release from mitochondria involves the VDAC (voltage-dependent anion channel) [7] [8] [9] . VDAC, also known as mitochondrial porin, lies in the OMM (outer mitochondrial membrane) and assumes a crucial position in the cell, forming the main interface between mitochondrial and cellular metabolisms, facilitating the exchange of adenine nucleotides, Ca 2+ and other metabolites and ions across the OMM [10, 11] . Rat VDAC1 (rVDAC1) contains two cysteine residues at positions 127 and 232, conserved in the rabbit, cattle, pig, rat, mouse and human proteins. The NMR-and crystallography-based three-dimensional structures of VDAC1 define a β-barrel composed of 19 β-strands and an α-helix at the N-terminus, with Cys 127 facing the lipid bilayer and Cys 232 facing the hydrophilic pore of the protein [12] [13] [14] . In addition to its metabolic and energetic functions, VDAC appears to serve more complex roles, such as participating in the release of cytochrome c and in apoptosis, as well as serving as a scaffold for proteins that modulate mitochondrial permeability, such as anti-and pro-apoptotic proteins [15] [16] [17] [18] [19] [20] . Accumulating evidence suggests the involvement of VDAC in ROS activity, either directly, via modification of its oxidative state [8, 9, 21, 22] , or indirectly, by serving as the channel mediating transport of ROS from the IMS (intermembrane space) to the cytoplasm [9] . It has also been shown that down-regulation of a cytosolic oxidoreductase, Grx1, leads to mitochondrial dysfunction through oxidative modification of VDAC [22] . O 2
•− -induced apoptosis is inhibited by DIDS (4,4 -di-isothiocyanostilbene-2,2 -disulfonate) [8] or anti-VDAC antibodies [8, 21] that block VDAC channel activity [23, 24] , suggesting that O 2
•− induces cytochrome c release via
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VDAC-dependent permeabilization of the OMM. Moreover, O 2 •− was found to evoke cytochrome c release from VDACreconstituted liposomes [8] . Finally, when overexpressed in HEK (human embryonic kidney)-293 cells, VDAC-bound hexokinase-I was found to decrease ROS release from mitochondria to the cytosol [25] .
Since it has been suggested that the oxidation state of VDAC affects apoptotic cell death, and since cysteine residues are major targets in oxidation/reduction reactions that may be involved in apoptosis, the importance of the two VDAC1 cysteine residues (Cys 127 and Cys 232 ) to VDAC1 function was addressed. The results suggest that the cysteine residues of VDAC1 are not involved in its transport activities or ROS-induced apoptosis. In addition, using thiol-specific modifying and cross-linking reagents, the topology of the two VDAC1 cysteine residues was determined, showing that one faces the VDAC1 pore and the second is oriented towards the lipid bilayer or to the cytosol, in accordance with the proposed VDAC1 membrane topology [12] [13] [14] . Plasmids and site-directed mutagenesis DNA encoding rVDAC1 [26] and cysteine-less rVDAC [C(127,232)A-rVDAC1] was generated by PCR using a QuikChange ® strategy (Stratagene) and cloned into the BamHI/NotI sites of the tetracycline-inducible pcDNA4/TO vector (Invitrogen) using rVDAC1 cDNA as template and the following primers. For C127A, reverse primer, 5 -CAAAGTC-CACATCAGCGCCCAGG-3 , and forward primer, 5 -CCTG-GGCGCTGATGTGGACTTTG-3 ; for C232A, reverse primer, 5 -CTTTGGCCGAAAAGGCGGCATCAGGGTCGAC-3 and forward primer, 5 -GTCGACCCTGATGCCGCCTTTTCGGCC-AAAG-3 . DNA sequences for rVDAC1-GFP (green fluorescent protein) or cysteine-less rVDAC1-GFP, encoding GFP conjugated to the VDAC C-terminus, were respectively cloned into KpnI/XbaI or BamHI/XbaI sites of the tetracyclineinducible pcDNA4/TO vector (Invitrogen). DNA encoding the C-terminal region of VDAC1 conjugated to GFP was excised from plasmid mVDAC-pcDNA4/TO-GFP and cloned into the BstI/XbaI sites of the rVDAC1-pcDNA4/TO or cysteine-less rVDAC1-pcDNA4/TO vector.
EXPERIMENTAL
Specific silencing of endogenous hVDAC1 (human VDAC1) was achieved using a shRNA (small hairpin RNA)-expressing vector. Nucleotides 337-355 of the hVDAC1 coding sequence were chosen as the target for shRNA. The hVDAC1-shRNAencoding sequence was created using the two complimentary oligonucleotides indicated below, each containing the 19 nt target sequence of hVDAC1 (337-355), followed by a short spacer and an antisense sequence of the target: Oligonucleotide 1, 5 -AG-CTTAAAAAACACTAGGCACCGAGATTATCTCTTGAATA-ATCTCGGTGCCTAGTGTG-3 and Oligonucleotide 2, 5 -GAT-CCACACTAGGCACCGAGATTATTCAAGAGATAATCTCG-GTGCCTAGTGTTTTTTA-3 . The hVDAC1-shRNA-encoding sequence was cloned into the BglII and HindIII sites of the pSUPERretro plasmid (OligoEngine), containing a puromycinresistance gene. Transcription of this sequence by RNA polymerase II produces a hairpin (hVDAC1-shRNA).
To generate VDAC for subsequent purification, rVDAC1 or C(127,232)A-rVDAC1 DNA sequences were cloned into the pYES2 plasmid, which was then introduced into the M22-2 porinless yeast strain.
Cell culture
HEK-T and T-REx-293 cells (tetracycline repressor-expressing HEK-293 cells) were grown in DMEM, supplemented with 10 % fetal calf serum, 2 mM L-glutamine, 100 units/ml penicillin, 100 μg/ml streptomycin, 1 mM sodium pyruvate and nonessential amino acids and maintained in a humidified atmosphere, at 37
• C with 5 % CO 2 . hVDAC1-shRNA T-REx-293 cells stably expressing the pSUPERretro vector encoding shRNA-targeting hVDAC1 and showing a low (10-20 %) level of endogenous hVDAC1 expression were grown with 0.5 μg/ml puromycin and 5 μg/ml blasticidin.
Overexpression of rVDAC1-pcDNA4/TO or cysteine-less rVDAC1-pcDNA4/TO was induced by tetracycline (2.5 μg/ml) for 96-112 h.
HEK-T cells were transiently transfected with the plasmids pcDNA4/TO-rVDAC1-GFP or cysteine-less rVDAC1-pcDNA4/TO-GFP, grown for 48 h and then visualized by confocal microscopy.
The Saccharomyces cerevisiae M22-2 por1-mutant strain expressing rVDAC1 or C(127,232)A-rVDAC1 was grown on selective medium (without uracil and leucine) overnight. The yeast were transferred on to YPL medium (1 % yeast extract, 1 % peptone and 2 % lactate) and, 36 h later, 2 % (w/v) galactose was added to induce expression. After 30 h, the yeast were harvested and used for VDAC purification.
siRNA (small interfering RNA) transfection and VDAC silencing experiments
T-REx-293 cells were seeded in a 12-well plate (50 000 cells/well). After 24 h, the cells were transfected with 25 nM hVDAC1-directed siRNA (synthesized by Dharmacon) using the DharmaFECT 1 transfection reagent, according to the manufacturer's instructions. After 16 h, growth medium was replaced and the cells were transfected further with the tetracycline-inducible pcDNA4/TO plasmid encoding rVDAC1 or cysteine-less rVDAC (0.5 μg/sample) using the calcium phosphate method. After 9 h, the medium was replaced and tetracycline (1.5 μg/ml) was added for 36 h, followed by treatment with 8 μM selenite for 16 h. Apoptosis was then measured using the Acridine Orange/ethidium bromide staining method [26] .
Apoptosis analysis
Apoptotic cells were counted by annexin V-FITC/PI and FACS analysis (FACScan, Beckton-Dickinson) and ModFITlt2.0 software or analysed by Acridine Orange and ethidium bromide staining [26] .
ROS production analysis
Cells expressing native or C(127,232)A-rVDAC1 were exposed to 25 μM As 2 O 3 for 24 h, and ROS production was monitored using the oxidant-sensitive DCFH-DA fluorescent probe, a cellpermeable indicator of ROS. DCFH-DA is activated by cellular esterases to yield DCFH (2 ,7 -dichlorodihydrofluorescein), which is converted into the DCF (2 ,7 -dichlorofluorescein) fluorescent derivative by H 2 O 2 and peroxidase. After washing with PBS, cells were loaded with 4 μM DCFH-DA for 30 min at 37
• C, thoroughly washed with PBS, trypsinized and resuspended in PBS. Fluorescence intensity was measured by FACS analysis.
Confocal microscopy
Cells (3 × 10 5 ) were grown on PDL-coated coverslips in a 60-mm-diameter dish and transfected with plasmids pcDNA4/TO-rVDAC1-GFP or pcDNA4/C(127,232)A-rVDAC1-TO-GFP. After 48 h, the cells were stained with 15 nM MitoTracker Red dye, washed with PBS, fixed for 20 min with 4 % (w/v) paraformaldehyde and rinsed with PBS before imaging by confocal microscopy (Olympus 1X81).
Chemical cross-linking
Control, native or cysteine-less rVDAC1-expressing T-REx-293 cells (3 mg/ml) were incubated with different concentrations of EGS in PBS (pH 8.3) at 30
• C for 15 min or were incubated with BMOE (1 mM) in PBS (pH 7.2) at 30
• C for 30 min. Samples (70 μg) were subjected to SDS/PAGE (10 % gels) and immunoblotting using anti-VDAC antibodies.
Mitochondria and VDAC labelling with, 5-FM, NEM or [ 14 C]NEM
Isolated mitochondria (1 mg/ml) were incubated with NEM (1 mM) for 30 min at 37
• C in PBS (pH 7.4) or with 75 μM 5-FM at 37
• C for 30 min in PBS. The membranes were collected by centrifugation at 14 000 g for 30 min at 4
• C and resuspended in 10 mM Tris/HCl (pH 7.4) and used for VDAC purification. For radiolabelling, purified VDAC isolated from unlabelled, NEM-or 5-FM-pre-labelled mitochondria was incubated with [
14 C]NEM (0.33 mM, 10 mCi/mmol) for 60 min at 37
• C in PBS and the reaction was terminated by the addition of SDS/PAGE sample buffer. NEM radiolabelling was visualized by autoradiography using X-ray film.
Purification of VDAC
For recombinant VDAC purification, rVDAC1 and C(127,232)ArVDAC1 were expressed in the S. cerevisiae M22-2 por1-mutant strain [26] and purified from mitochondria as was VDAC from rat liver mitochondria. Rat liver mitochondria in 10 mM Tris/HCl (pH 7.2) were incubated with 2 % LDAO at 4
• C for 20 min followed by centrifugation at 20 000 g for 30 min and the supernatant obtained was loaded on to a dry celite/hydroxyapatite (2:1, v/v) column. VDAC was eluted with a solution containing 2 % LDAO, 10 mM Tris/HCl (pH 7.2), 50 mM NaCl and 22 mM NaH 2 PO 4 . The VDAC-containing fractions were dialysed against 10 mM Tris/HCl (pH 7.2) and subjected to a second chromatography step on a CMC (carboxymethyl-cellulose) column from which VDAC was eluted with a solution containing 10 mM Tris/HCl (pH 7.2), 0.3 % LDAO and 500 mM NaCl. VDAC was also isolated from rat liver mitochondria pre-labelled with 75 μM 5-FM or 1 mM NEM, following solublization with LDAO and chromatography on hydroxyapatite, as described above.
VDAC channel reconstitution, recording and analysis
Unlabelled, 5-FM-or NEM-labelled VDAC purified from rat liver mitochondria, and rVDAC1 or C(127,232)A-rVDAC1 expressed and purified from yeast were reconstituted into a PLB (planar lipid bilayer). Single-channel current recording and data analysis were carried out as described previously [27] . Briefly, PLB was prepared from soya bean asolectin dissolved in 50 mg/ml ndecane. Purified VDAC was added to the chamber defined as the cis side. After one or a few channels were inserted into the PLB, excess protein was removed by washing the cis chamber with 20 volumes of solution to prevent further incorporation. Currents were recorded under voltage-clamp using a Bilayer Clamp BC-535B amplifier (Warner Instruments). Currents were measured with respect to the trans side of the membrane (ground). The currents were low-pass-filtered at 1 kHz, and digitized online using a Digidata 1440-interface board and PCLAMP 10.2 software (Axon Instruments).
Gel electrophoresis and immunoblot analysis
SDS/PAGE was performed using the method of Laemmli [28] . Gels were stained with Coomassie Brilliant Blue. For immunostaining, membranes containing electrotransferred proteins were blocked with 5 % (w/v) non-fat dried milk powder and 0.1 % Tween 20 in Tris-buffered saline, incubated with monoclonal anti-VDAC antibodies (1:10 000) and then with alkaline-phosphatase-conjugated anti-mouse IgG or HRPconjugated anti-mouse IgG secondary antibodies (1:10 000). Antibody binding was detected using enhanced chemiluminescent substrate (Pierce) for detection of HRP.
RESULTS
rVDAC1 contains two cysteine residues, Cys 127 and Cys 232 , that are also conserved in the rabbit, cattle, pig, rat, mouse and human proteins (Figure 1 ). In the present study, the topology of the two VDAC cysteine residues with respect to the VDAC internal pore and protein-lipid interface, as well as the requirement for these cysteine residues in VDAC1 activity and function in cell death, were addressed. These were assessed by employing several reagents that modify free thiol groups or cross-link them, and by constructing a cysteine-less version of VDAC1, i.e. C(127,232)ArVDAC1, expressing the mutated protein in VDAC1-shRNA cells presenting low levels of endogenous hVDAC1, and then monitoring cell apoptosis induction by ROS-producing agents in each case.
Mitochondrial and purified VDAC labelling with the reagents 5-FM and NEM
NEM, an alkylating agent that binds to free thiol groups, and the bulky anionic probe 5-FM [29] , which specifically alkylates the thiol residue of the exposed cysteine side chain, were used to study the effect of cysteine modification on VDAC activity. Figure 2 presents the protein profile, fluorescence labelling with 5-FM and VDAC immunoblotting of the mitochondrial protein content. Whereas 5-FM labelled over 12 mitochondrial proteins, such labelling was almost completely abolished upon pre-incubation with NEM (Figure 2A ), suggesting that NEM essentially labelled all cysteine residues in these proteins. Purified VDAC was 5-FM-labelled, but not when purified from mitochondria pre-treated with NEM and then challenged with 5-FM, indicating that NEM interacted with the two VDAC1 cysteine residues to prevent 5-FM binding. This is also supported by the finding that no labelling of NEM-labelled purified VDAC by 5-FM was obtained, even in the presence of SDS. It should be noted that 5-FM-labelled VDAC showed modified mobility, probably due to the additional reagent mass (427 Da).
To verify whether the negatively charged 5-FM is able to interact with both VDAC1 cysteine residues, we tested the 14 C]NEM of either NEM-or 5-FM-pre-treated VDAC was obtained, suggesting that both VDAC1 cysteine residues were pre-labelled not only by NEM, but also by 5-FM. These findings thus raise questions about the positions of the cysteine residues in VDAC with respect to the membrane and the various proposed VDAC1 topology models, as discussed below.
Channel activity of NEM-and 5-FM-labelled VDAC and of cysteine-less VDAC1
Purified rat liver mitochondrial VDAC was reconstituted into a PLB and its channel activity was studied under voltage-clamp conditions (Figure 3 ). Current passing through VDAC in response to voltage stepped from a holding potential of 0 mV to +10 mV was recorded before and after the addition of 5-FM. At relatively small membrane potentials (+10 mV), channel conductance remained constant for up to 60 min of recording ( Figure 3A) . However, upon addition of 5-FM, the open channel was stabilized in its low-conducting state ( Figure 3A) . Such 5-FM-promoted decrease in VDAC conductance was observed at all voltages tested, with VDAC adopting a constant conductance, regardless of the voltage gradient applied ( Figure 3C ). For comparison, the effect of the smaller cysteine-modifying probe, NEM, on the channel activity was also tested. NEM had no effect on VDAC channel conductance ( Figure 3C ). Since NEM had no effect on channel conductance, the observed decrease in VDAC conductance obtained with 5-FM could not be due to cysteine modification. Instead, the decrease in conductance probably resulted from the interaction of the bulky 5-FM molecule with a cysteine residue facing the pore, an interaction that subsequently blocked the flow of ions through the VDAC pore.
Next, the channel activity of VDAC purified from control or NEM-pre-labelled mitochondria, following their reconstitution into a PLB, was analysed ( Figure 3B ). NEM-labelled VDAC showed channel conductance similar to that of the non-labelled protein. Moreover, 5-FM had no effect on the conductance of the NEM-labelled channel, suggesting that the cysteine residue in VDAC involved in the effect of 5-FM on channel conductance was labelled by NEM ( Figure 3B) . Furthermore, the results also show that similar voltage-dependent conductance was obtained with unlabelled or NEM-or 5-FM-labelled VDAC ( Figure 3C ), suggesting that VDAC cysteine residues are not involved in the voltage gating of the channel. The results indicate further that the decrease in VDAC channel conductance mediated by 5-FM (but not by NEM) is not due to modification of VDAC cysteine residues, but rather results from a physical decreasing of the pore size by the bulky 5-FM blocking the pore and thus decreased channel conductance.
To demonstrate further that VDAC1 cysteine residues are not essential for the channel activity of the protein, a mutated version of rVDAC1 in which the two cysteine residues, Cys 127 and Cys 232 , were replaced by alanine residues, i.e. C(127,232)ArVDAC1, was constructed and expressed in porin-less yeast. The mutated protein, purified from porin-lacking yeast mitochondria, showed channel conductance and voltage-dependence similar to that of native rVDAC1, following reconstitution into a PLB ( Figure 3D ). As expected, the channel conductance of the cysteine-less rVDAC1 was not reduced by 5-FM (results not shown).
The thiol-specific cross-linker BMOE reveals the location of VDAC1 cysteine residues with respect to the pore and their interactions with associated proteins
To address VDAC1 cysteine residue location in the interface of the protein with the bilayer, the membrane-permeable thiolspecific cross-linking reagent BMOE was employed. Isolated mitochondria exposed to BMOE yielded VDAC dimers and a protein band that might represent VDAC trimers or another VDAC-containing complex (Figure 4) , similar to the cross-linked products obtained with EGS, an amine residue-specific crosslinker. These products resulted from the interaction of BMOE with cysteine residues, since such adducts were not obtained with NEM-or 5-FM-prelabelled mitochondria ( Figure 4A ). Furthermore, BMOE produced no cross-linked products in cells expressing C(127,232)A-rVDAC1. These findings indicate clearly that BMOE is indeed a thiol-specific reagent and suggest that one or both VDAC1 cysteine residue(s) lay on the β-barrel surface facing the bilayer or, alternatively, lay on the cytosolic face of VDAC. Owing to the close proximity of two or more VDAC molecules, the thiol-reactive reagent cross-linked these VDAC molecules through the accessible cysteine residues.
Upon exposure of T-REx-293 cells expressing native or C(127,232)A-rVDAC1 to BMOE followed by SDS/PAGE and immunoblotting using anti-VDAC antibodies, a large number of VDAC1-containing complexes were obtained in cells expressing native rVDAC1, but not C(127,232)A-rVDAC1 ( Figure 4B ). Since such VDAC1-containing complexes were not obtained when isolated mitochondria were exposed to BMOE (Figure 4A) , some of the VDAC1-containing complexes most probably include VDAC-associated cytosolic proteins. These results thus suggest the involvement of the VDAC1 cysteine residues in the interaction of VDAC with associated proteins. This is not surprising, since VDAC was shown to interact with a large number of proteins, including hexokinase, actin, tubulin, creatine kinase and members of the Bcl2 family of proteins [18] .
C(127,232)A-rVDAC1 is localized to mitochondria, functions in apoptosis and undergoes oligomerization
To demonstrate that C(127,232)A-rVDAC1 is localized to the mitochondrial membrane, a C(127,232)A-rVDAC1-GFP fusion protein was constructed and expressed in HEK-T cells. The intracellular distribution of the chimera, as compared with rVDAC1-GFP and to the mitochondrial marker MitoTracker Red, was visualized by confocal microscopy ( Figure 5 ). As expected for a mitochondrially distributed protein, C(127,232)ArVDAC1-GFP fluorescence was punctate and co-localized with MitoTracker Red, showing that cysteine-less VDAC1-GFP is localized to mitochondria.
To verify the requirement of VDAC1 cysteine residues for VDAC function in apoptosis, C(127,232)A-rVDAC1 was expressed under the control of tetracycline in VDAC1-shRNA-TREx-293 cells or transfected with siRNA, expressing low levels of endogenous hVDAC1. Under the conditions used, endogenous VDAC represents 5-20 % of the expressed VDAC content (see Figures 7C, 7D and 8C) .
Overexpression of human, mouse, Paralichthys olivaceus (Japanese flounder) and rice VDAC1 was found to induce apoptotic cell death, regardless of the cell type [26, [30] [31] [32] . As such, it was next examined whether overexpression of C(127,232)A-rVDAC1 can induce cell death, as does native rVDAC1. When overexpressed in T-REx-293 cells, both native and cysteine-less-rVDAC1 induced apoptosis ( Figure 6A ).
We have recently demonstrated that induction of apoptotic cell death by VDAC1 overexpression is associated with VDAC oligomerization [33] . To examine the oligomeric state of cysteineless rVDAC1, cells were transfected to overexpress native or C(127,232)A-rVDAC1 upon exposure to tetracycline for 105 h, incubated with the cross-linker EGS, followed by SDS/PAGE and immunoblotting using anti-VDAC antibodies ( Figure 6B) . The results showed that overexpression of C(127,232)A-rVDAC1 was accompanied by the appearance of dimers and higher oligomers of VDAC1 as with native rVDAC1.
Next, to test whether cysteine residues may be involved in apoptosis upon their oxidation by ROS, apoptosis was induced by H 2 O 2 or the hydroxyl radical generators As 2 O 3 [5, 6] or sodium selenite, shown to induce oxidative stress and permeability transition pore opening [34] .
Control, hVDAC1-shRNA cells and hVDAC1-shRNA cells expressing native or cysteine-less rVDAC1 were exposed to selenite and apoptotic cell death was analysed using annexin Figures 7A and 7B) . A similar extent of apoptosis was induced by selenite in control cells and in cells expressing native or cysteine-less rVDAC1 ( Figures 7A  and 7B ), and to lesser extent in hVDAC1-shRNA-treated cells expressing low levels of endogenous hVDAC1 ( Figure 7C) .
V-FITC and PI and FACS analysis (
In a similar experiment, siRNA directed against hVDAC1, but allowing expression of native or cysteine-less rVDAC1, was used ( Figure 7E) . The results show clearly that selenite induced a 5-fold increase in apoptosis in cells expressing endogenous, native or cysteine-less VDAC1, but only a 2-fold increase in cells where the level of endogenous VDAC1 was reduced by approx. 90 % (see Figure 7D ). This is in agreement with the finding of VDACdependent, selenite-induced apoptosis in COS7 cells [35] . Similar results were obtained with H 2 O 2 (not shown) and As 2 O 3 ( Figures 8A and 8B) . The results also show that As 2 O 3 indeed induces ROS production to a similar extent in both cell types ( Figures 8D and 8E) , as revealed using the cell-permeable oxidantsensitive dye DCFH-DA. It can thus be concluded that apoptosis induction by H 2 O 2 or ROS, as generated by As 2 O 3 or selenite, does not involve oxidation of VDAC1 cysteine residues.
DISCUSSION
Thiol-dependent redox systems are involved in the regulation of diverse biological processes, such as responses to stress, signal transduction and protein folding. In the present study, we have addressed the requirement of VDAC cysteine residues for channel activity and function in cell apoptosis, as induced by different means, including ROS production. We have also considered the positions of VDAC1 Cys 127 and Cys 232 with respect to the membrane and channel pore, and in the light of proposed VDAC1 topology models.
Topology of VDAC1 cysteine residues and their function in channel activity
The effects of the thiol-modifying reagents NEM and the bulky charged reagent 5-FM on PLB-reconstituted VDAC conductance allowed us to determine the topology of Cys 127 and Cys 232 , with respect to the membrane and the channel pore. We found that the bulky charged 5-FM, but not the smaller NEM, reduced VDAC channel conductance (Figure 3) , and that both reagents interacted with the two VDAC cysteine residues. This latter point is supported by the finding that 5-FM had no effect on the conductance of NEM-pre-labelled VDAC ( Figure 3B ). In addition, [ 14 C]NEM labelled purified native VDAC, but not NEMor 5-FM-pre-labelled protein ( Figure 2 ). Since purified bilayerreconstituted cysteine-less VDAC1 showed the same channel properties as did native VDAC1 ( Figure 3D ), and since 5-FM had no effect on the channel conductance of cysteine-less VDAC, it is clear that 5-FM decreased conductance due to its interaction with a VDAC1 cysteine residue. These findings suggest that the effect of 5-FM on channel conductance is not due to alkylation of the thiol residue of the exposed cysteine side chain, as also occurs with NEM, but rather is a result of 5-FM reacting with a cysteine residue facing the pore, thereby interfering with the ionic current flow.
According to recently proposed NMR-and crystallographybased VDAC1 structures, Cys 232 lines the VDAC1 pore, whereas Cys 127 faces the membrane, or may be exposed to the cytosol [12] [13] [14] 36] . Our findings are thus in agreement with the proposed topology of at least one cysteine residue facing the VDAC pore. Since 5-FM is a negatively charged membrane-impermeable reagent [37] , its ability to interact with both cysteine residues (Figure 2 ) argues against the proposed location of one of the VDAC1 cysteine residues as facing the membrane [12] [13] [14] . However, our results also demonstrate that the membranepermeable thiol-specific cross-linking reagent BMOE crosslinked native VDAC in mitochondria to form dimers and possibly trimers, but not following NEM-or 5-FM-pre-labelling of mitochondria, suggesting that cysteine residues in two VDAC molecules are oriented towards each other and are thus available for cross-linking. This observation could, however, be explained by assuming that the negatively charged 5-FM is membranepermeable, or that one of the VDAC cysteine residues is not located in a transmembrane β-strand, but rather faces the cytosol. The latter suggestion is in agreement with recently proposed NMR-and crystallography-based topologies [12] [13] [14] and with biochemical-based [38] models, but not with other earlier proposed biochemical-and function-based VDAC1 topology models [10] . Our findings thus can contribute to the recent discussion concerning discrepancies between the various proposed VDAC1 transmembrane folding patterns [36] .
Regardless of their locations, the highly conserved VDAC1 Cys 127 and Cys 232 are not essential for channel activity, since the bilayer-reconstituted channel activity of C(127,232)A-rVDAC1 was similar to that of native rVDAC1, with respect to conductance and voltage-dependence ( Figure 3D ). This may suggest that the VDAC1 cysteine residues are not required for VDAC1-mediated transport of ions, nucleotides or other metabolite exchange between the mitochondrial IMS and the cytosol.
With respect to conflicting data concerning the orientation and topology of VDAC in the OMM, the finding that cysteine-less VDAC1 functions as a channel and in apoptosis as does native VDAC1 allows the use of the mutant to study protein membrane topology by using cysteine-scanning and membrane-permeable and -impermeable thiol-interacting reagents, e.g. the methanethiosulfonate reagents MTSET {[2-(trimethylammonium)ethyl] methane thiosulfonate} and MTSBn (benzyl methanethiosulfonate) respectively. 
VDAC1 cysteine residues function in apoptosis
The results of the present study show that VDAC1 cysteine residues are not required for apoptosis induction (Figures 7 and  8 ). This is important since ROS play a key role in the promotion of cytochrome c release from mitochondria [2] [3] [4] 21] . It has been shown that O 2
•− -induced apoptosis is inhibited by DIDS or anti-VDAC antibodies [7, 8] , both blockers of VDAC activity [23, 24] , suggesting that O 2
•− induces cytochrome c release via VDACdependent permeabilization of the OMM [8] . Moreover, O 2
•− was found to evoke cytochrome c release in VDAC-reconstituted liposomes [8] , VDAC was, moreover, shown to control the release of superoxide from the mitochondrial IMS to the cytoplasm [9] . In addition, furanonaphthoquinone was proposed to cause apoptosis of cancer cells by inducing the production of ROS by VDAC [7] . These observations suggest an involvement of VDAC in ROS transport to the cytosol and in apoptosis induction. Our results suggest that cysteine residues in VDAC1 are not involved in such ROS-induced apoptosis, since apoptosis was induced by H 2 O 2 , selenite and As 2 O 3 (Figures 7 and 8) , each acting via generation of hydroxyl radicals [5, 6, 34] (see also Figures 8D and 8E ), in cells expressing cysteine-less rVDAC1. In addition, we demonstrated that VDAC1 cysteine residues are not required or even involved in VDAC1 oligomerization (Figure 6 ), proposed to be associated with apoptosis induction [33] .
To summarize, the results of the present study suggest that VDAC1 cysteine residues, although conserved from yeast to mammals, are not required for VDAC channel activity, VDAC1 oligomerization or for VDAC1-mediated apoptosis.
